The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.
April 23rd 2024
The principal investigator of the study leading to approval said this new immunotherapy could be a "game changer" in bladder cancer.